Disturbed bile acid metabolism leads to insufficient activation of the bile acid receptor FXR, which is responsible for reduced energy expenditure, increased lipogenesis, and increased bile acid synthesis that affects NAFLD progression (Clifford et al., 2021). The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.